A phase III study to evaluate triple combination of buntanetap and other drugs, including Trulicity and Viagra to enhance cognitive function
Latest Information Update: 13 Oct 2024
At a glance
- Drugs Buntanetap (Primary) ; Dulaglutide (Primary) ; Sildenafil (Primary)
- Indications Alzheimer's disease; Cognition disorders; Parkinson's disease
- Focus Therapeutic Use
- 13 Oct 2024 New trial record
- 03 Oct 2024 According to Annovis Bio media release, the company has secured intellectual property for innovative combination therapy involving buntanetap and other drugs, including Trulicity and Viagra.